Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies (Anthracycline Chemotherapy) – Online Calculator
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies (Anthracycline Chemotherapy) from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society (HFA-ICOS).
| Risk factors | Score | Level of evidence |
| Previous cardiovascular disease | ||
| Heart failure or cardiomyopathy | Very high | B |
| Severe valvular heart disease | High | C |
| Myocardial infraction or previous coronary revascularization (PCI or CABG) | High | C |
| Stable angina | High | C |
| Baseline LVEF <50% | High | B |
| Borderline LVEF 50-54% | Medium2 | C |
| Cardiac biomarkers (where available) | ||
| Elevated baseline troponin | Medium1 | C |
| Elevated baseline BNP or NT-proBNP | Medium1 | C |
| Demographic and cardiovascular risk factors | ||
| Age ≥80 years | High | B |
| Age 65–79 years | Medium2 | B |
| Hypertension | Medium1 | B |
| Diabetes mellitus | Medium1 | C |
| Chronic kidney disease | Medium1 | C |
| Previous cardiotoxic cancer treatment | ||
| Previous anthracycline exposure | High | B |
| Prior radiotherapy to left chest or mediastinum | High | C |
| Previous non-anthracycline-based chemotherapy | Medium1 | C |
| Lifestyle risk factors | ||
| Current smoker or significant smoking history | Medium1 | C |
| Obesity (BMI >30 kg/m2) | Medium1 | C |
a Elevated above the upper limit of normal for local laboratory reference range.
b Systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg, or on treatment.
c Glycated haemoglobin >7.0% or >53 mmol/mol, or on treatment.
d Estimated glomerular filtration rate <60 mL/min/1.73 m2.
HFA-ICOS risk assessment
| no risk factor OR one medium1 risk factor | Low risk | <2% |
| medium risk factors with a total of 2–4 points | Medium risk | 2-9% |
| medium risk factors with a total of ≥5 points OR any high risk factor | High risk | 10-19% |
| any very high risk factor | Very high risk | >20% |
Register on our website right now to have access to more learning materials!
Subscribe to our pages:
AI-Driven Patient Simulator – Quick Feedback
🗣️ We Value Your Feedback Thank you for your interest in the AI-Driven Patient Simulator!…
Get Early Access AI-Driven Patient Simulator
Try the AI-Driven Patient Simulator and explore the future of medical education 🧠 Try the…
Celebrating a Major Milestone: SESAM Recognizes ClinCaseQuest’s Defragmented Debriefing Model as an Advancement in Clinical Simulation 2024
At ClinCaseQuest, we are thrilled to announce an outstanding achievement in the field of medical…
Acute Pulmonary Edema: Emergency Care Algorithm – Should We Remove or Redistribute the Fluid?
Case Presentation: A 64-year-old man was transported to the emergency department by ambulance due to…
ClinCaseQuest Featured in SchoolAndCollegeListings Directory
Exciting News Alert! We are thrilled to announce that ClinCaseQuest has been successfully added to…
Сounseling a patient with suspected Takotsubo-syndrome OSCE guides
The onset of the consultation Wash hands and put on PPE if necessary. Introduce yourself…
